Literature DB >> 22869762

A practical guide to the treatment of neuromyelitis optica.

Jackie Palace1, Maria Isabel Leite, Isobel Leite, Anu Jacob.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22869762     DOI: 10.1136/practneurol-2012-000237

Source DB:  PubMed          Journal:  Pract Neurol        ISSN: 1474-7758


× No keyword cloud information.
  13 in total

1.  Treatment of MOG antibody associated disorders: results of an international survey.

Authors:  D H Whittam; V Karthikeayan; E Gibbons; R Kneen; S Chandratre; O Ciccarelli; Y Hacohen; J de Seze; K Deiva; R Q Hintzen; B Wildemann; S Jarius; I Kleiter; K Rostasy; P Huppke; B Hemmer; F Paul; O Aktas; A K Pröbstel; G Arrambide; M Tintore; M P Amato; M Nosadini; M M Mancardi; M Capobianco; Z Illes; A Siva; A Altintas; G Akman-Demir; L Pandit; M Apiwattankul; J Y Hor; S Viswanathan; W Qiu; H J Kim; I Nakashima; K Fujihara; S Ramanathan; R C Dale; M Boggild; S Broadley; M A Lana-Peixoto; D K Sato; S Tenembaum; P Cabre; D M Wingerchuk; B G Weinshenker; B Greenberg; M Matiello; E C Klawiter; J L Bennett; A I Wallach; I Kister; B L Banwell; A Traboulsee; D Pohl; J Palace; M I Leite; M Levy; R Marignier; T Solomon; M Lim; S Huda; A Jacob
Journal:  J Neurol       Date:  2020-07-04       Impact factor: 4.849

Review 2.  Neuromyelitis optica spectrum disorders.

Authors:  Saif Huda; Dan Whittam; Maneesh Bhojak; Jayne Chamberlain; Carmel Noonan; Anu Jacob
Journal:  Clin Med (Lond)       Date:  2019-03       Impact factor: 2.659

Review 3.  Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders.

Authors:  Ingo Kleiter; Ralf Gold
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

Review 4.  What's new in neuromyelitis optica? A short review for the clinical neurologist.

Authors:  Daniel Whittam; Martin Wilson; Shahd Hamid; Geoff Keir; Maneesh Bhojak; Anu Jacob
Journal:  J Neurol       Date:  2017-03-13       Impact factor: 4.849

Review 5.  Aquaporins: important but elusive drug targets.

Authors:  Alan S Verkman; Marc O Anderson; Marios C Papadopoulos
Journal:  Nat Rev Drug Discov       Date:  2014-03-14       Impact factor: 84.694

6.  Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes.

Authors:  Maciej Juryńczyk; Brian Weinshenker; Gulsen Akman-Demir; Nasrin Asgari; David Barnes; Mike Boggild; Abhijit Chaudhuri; Marie D'hooghe; Nikos Evangelou; Ruth Geraldes; Zsolt Illes; Anu Jacob; Ho Jin Kim; Ingo Kleiter; Michael Levy; Romain Marignier; Christopher McGuigan; Katy Murray; Ichiro Nakashima; Lekha Pandit; Friedemann Paul; Sean Pittock; Krzysztof Selmaj; Jérôme de Sèze; Aksel Siva; Radu Tanasescu; Sandra Vukusic; Dean Wingerchuk; Damian Wren; Isabel Leite; Jacqueline Palace
Journal:  J Neurol       Date:  2015-11-03       Impact factor: 4.849

7.  Longitudinally extensive myelitis in MS mimicking neuromyelitis optica.

Authors:  Daniel Whittam; Maneesh Bhojak; Kumar Das; Anu Jacob
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2017-02-14

Review 8.  Spinal Cord Involvement in MS and Other Demyelinating Diseases.

Authors:  Mariano Marrodan; María I Gaitán; Jorge Correale
Journal:  Biomedicines       Date:  2020-05-22

9.  Cases of neuromyelitis optica spectrum disorder from the East Africa region, highlighting challenges in diagnostics and healthcare access.

Authors:  Dilraj Sokhi; Adil Suleiman; Soraiya Manji; Juzar Hooker; Peter Mativo
Journal:  eNeurologicalSci       Date:  2021-01-23

Review 10.  Rituximab for the treatment of multiple sclerosis: a review.

Authors:  Clara Grazia Chisari; Eleonora Sgarlata; Sebastiano Arena; Simona Toscano; Maria Luca; Francesco Patti
Journal:  J Neurol       Date:  2021-01-08       Impact factor: 6.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.